A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis

NCT02809781 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

250

Enrollment

OTHER

Sponsor class

Conditions

Spondylitis
Spondylitis, Ankylosing
Ankylosis
Arthritis
Spondylarthritis
Spondylarthropathies
Spinal Diseases
Musculoskeletal Diseases
Bone Diseases

Interventions

BIOLOGICAL: Intravenous infusion of MSCs
DRUG: Etanercept

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Collaborators

[object Object]
[object Object]